Main content

Ben Boulos explores the impact lower prices for weight-loss and diabetes drugs like Ozempic and Mounjaro could have on the global food and drinks business. He asks whether they really could add billions to the UK's economic growth.

30 days left to watch

25 minutes

Last on

Tue 13 Jan 202601:30

Broadcasts